Hunan Er-Kang Pharmaceutical Co.,Ltd.’s Net Profit Dropped 71.4% in First Half of 2022

Hunan Er-Kang Pharmaceutical Co.,Ltd. (湖南尔康制药股份有限公司) (300267.SZ) reported a net profit of 27.1 million yuan in the first half of 2022, down 71.4% year-on-year.

Meanwhile, the company posted 870.6 million yuan in revenue, up 4.6% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 578.1 million yuan in total liabilities, with a liability-to-asset ratio of 10.4%.